Medico Remedies Limited (NSE:MEDICO)
46.80
-0.32 (-0.68%)
May 22, 2026, 3:29 PM IST
Medico Remedies Revenue
In the fiscal year ending March 31, 2026, Medico Remedies had annual revenue of 2.12B INR with 40.66% growth. Medico Remedies had revenue of 596.82M in the quarter ending March 31, 2026, with 44.50% growth.
Revenue
2.12B
Revenue Growth
+40.66%
P/S Ratio
1.87
Revenue / Employee
9.97M
Employees
213
Market Cap
3.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.12B | 613.70M | 40.66% |
| Mar 31, 2025 | 1.51B | 60.20M | 4.15% |
| Mar 31, 2024 | 1.45B | 44.83M | 3.19% |
| Mar 31, 2023 | 1.40B | 194.16M | 16.04% |
| Mar 31, 2022 | 1.21B | -13.69M | -1.12% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nectar Lifesciences | 16.70B |
| Ind-Swift Laboratories | 5.94B |
| Sigachi Industries | 4.85B |
| Beta Drugs | 3.96B |
| Jagsonpal Pharmaceuticals | 2.87B |
| Balaxi Pharmaceuticals | 2.76B |
| Valiant Laboratories | 2.37B |
| Bafna Pharmaceuticals | 1.47B |
Medico Remedies News
- 8 months ago - Medico Remedies shares surge nearly 5% after winning $1.78 million order from Turkmenistan government - Business Upturn